Profectus begins Phase 1 clinical study of VesiculoVax-vectored Ebola virus vaccine

In preclinical studies, a single dose of this vaccine completely protected monkeys against the strain of Ebola virus responsible for the recent outbreak … Full Article http://j.gs/5sTq

Click here to read full article